Six-year RCSI higher specialty training programme (ST3-ST8) in vascular surgery, a specialty separated from general surgical training, entered after Core Surgical Training and the MRCS.
6 years (ST3-ST8)
Duration
Annual intake: Indicative 2027 appointable range: 5–8 ST3 posts, subject to NDTP/ISPTC agreement and change.
Applications: July 2027: direct Pathway applications 15 October–13 November 2026. ESR applications open 14 October 2026 at 12 noon and close 13 November 2026 at 12 noon; submit the required hard copy. Eligible academic and final-six-month clinical evidence updates are accepted to 8 January 2027. The ESR form lists 18 March 2027 for interview, subject to confirmation; confirm your individual invitation because the intake guide gives a broader March timetable.
Entry: After CST (ST1–ST2) and MRCS, through direct CST2-to-ST3 Pathway progression or the Equivalent Standards Route (ESR). ESR applicants need at least 12 months full-time equivalent experience in the chosen specialty; certified CST-equivalent training and prescribed evidence/assessments are required.
Exams: MRCS required for ST3 eligibility (completed during CST). RCSI states successful completion of the FRCS exam is required to achieve CCST at the end of training; the FEBVS is not mentioned on RCSI's vascular pages.
Higher specialty training in vascular surgery in Ireland is a six-year RCSI programme (ST3-ST8). Formerly part of general surgical training, vascular surgery became a separate specialty as case volume, complexity and minimally invasive endovascular techniques grew; RCSI notes about half of vascular patients present urgently or as emergencies. Successful completion of the FRCS exam is required for the Certificate of Completion of Surgical Training and Irish Medical Council registration eligibility.
Work and interests
Vascular practice treats arterial, venous and lymphatic disease, including aneurysms and diabetic foot complications. A substantial emergency workload sits alongside planned care and increasingly minimally invasive endovascular treatment.
Entry and selection for 2027
Entry is through direct progression from CST2 or ESR after completed CST or recognised equivalent training and the MRCS. ESR requires at least 12 months full-time equivalent experience in the chosen specialty, with logbooks, trainer reports, qualification evidence and any required operative-skills/human-factors assessments. Medical Council and English-language eligibility also apply.
For 2027, direct Pathway scoring is CST500 (CAPA/logbook/OSCEs 425 and weighted MRCS PartB75), academic 40 and interview 460, totalling 1000. The five interview weights are 100,40,100,120 and 100 for quality/safety, academic development, current surgical issues, decision making, and professionalism/probity respectively.
ESR uses a separate model: qualifying CST/equivalence earns 0 marks; post-CST clinical experience is assessed out of 45 and academic achievement out of 55, with the combined score rescaled to 600. The five interview stations carry 80 marks each (400 total). Do not add the Pathway and ESR scorecards together.
Both routes require at least 60% pre-interview and 60% overall interview, plus a mandatory 60% pass in decision-making station 4. Passing the aggregate cannot compensate for failing that station. For ESR, reaching 60% does not guarantee an interview; a 3:1 applicant-to-post shortlist may be used.
Applying
July 2027: direct Pathway applications 15 October–13 November 2026. ESR applications open 14 October 2026 at 12 noon and close 13 November 2026 at 12 noon; submit the required hard copy. Eligible academic and final-six-month clinical evidence updates are accepted to 8 January 2027. The ESR form lists 18 March 2027 for interview, subject to confirmation; confirm your individual invitation because the intake guide gives a broader March timetable.
How selection is scored
2027 Pathway: CST recordmax 500
CAPA1–3, trainer reports, logbook and operative skills/human factors OSCEs425
Weighted MRCS Part B score75
Pathway is direct progression from CST2. MRCS PartB is weighted according to examination sitting; do not substitute the FRCS exit examination.
Publications (papers 6–20; invited review up to 8; book chapters 4 each; case reports 2 each)30
Scientific presentations (2 each)10
Research prizes (international 10; national 6)10
Approved specialty/clinical courses (5 each)10
Overall academic component is limited to 40. Item maxima are alternatives/caps, not a sum to add to the final score. Final acceptance and attendance evidence is required; see the intake guide for ground rules.
2027 Pathway: interviewmax 460
Quality and safety in surgical healthcare100
Commitment to academic advancement and lifelong learning40
Current issues relevant to surgical practice100
Decision making in surgery (mandatory 60% pass)120
Professionalism and probity in surgical practice100
Pathway total 1000: CST500 + academic 40 + interview 460. Minimum 60% pre-interview and 60% overall interview, plus 60% in station 4.
This ESR route replaces the Pathway stages above. CST/equivalence, MRCS and relevant assessments are eligibility requirements; CST itself earns 0 marks in GuideA/T&O. Combined clinical 45 + academic 55 is rescaled to 600 before interview.
Other higher degrees/awards (Masters up to 35; higher diploma 25; diploma 18; certificate 12)35
Publications55
Presentations18
Research prizes18
Approved courses (2 each)10
Total academic score is limited/rescaled to 55. Only the highest qualifying degree is credited. The guide has editorial inconsistencies in some subcategory wording; consult RCSI for borderline scoring.
2027 ESR alternative: interviewmax 400
Quality and safety in surgical healthcare80
Commitment to academic advancement and lifelong learning80
Current issues relevant to surgical practice80
Decision making in surgery (mandatory 60% pass)80
Professionalism and probity in surgical practice80
ESR total 1000: pre-interview clinical/academic score rescaled to 600 + interview 400. Minimum 60% pre-interview,60% interview, and 60% decision-making station 4. Meeting 60% does not guarantee an interview; a 3:1 applicant-to-post shortlist may apply.
2027 Pathway: CST500 + academic 40 + interview 460 =1000. Both routes require at least 60% pre-interview and 60% overall interview, plus a mandatory 60% pass in decision-making station 4. Passing the aggregate cannot compensate for failing that station. For ESR, reaching 60% does not guarantee an interview; a 3:1 applicant-to-post shortlist may be used. ESR is an alternative route: clinical 45+academic 55 rescaled to 600, plus interview 400; do not sum both routes.
Entry and selection guidance checked 26 October 2026.
Facts last verified 2026-07-27. Content updated 2026-10-26.
We use cookies to save your ranking progress and preferences. Strictly necessary cookies keep the tool working. Optional cookies help us understand how the tool is used.